NEOJF yields 2.73% · PFE yields 6.13%● Live data
📍 NEOJF pulled ahead of the other in Year 1
Combined, NEOJF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NEOJF + PFE for your $10,000?
NEOJAPAN Inc. engages in development and sale of packaged software to small and medium-sized enterprises, large companies, schools, hospitals, local governments, and public agencies in Japan and internationally. The company offers desknet's NEO, a groupware software; AppSuite, a tool to create custom business applications; and ChatLuck, a chat-based business communication tool. It also provides Denbun, a web-based email system for corporate clients that manages, sends, and receives emails through a web browser; desknet's DAX, a file transfer system; desknet's SSS, a web-based sales management system, which enables to monitor progress in business negotiations, client info, and sales; and desknet's CAMS, a web-based customer relationship management system. In addition, it provides multi-application integration and hosting services; and system integration services, such as e-business system, e-commerce website, infrastructure and middleware, application service provider website construction, and online information distribution services. The company was incorporated in 1992 and is headquartered in Yokohama, Japan.
Full NEOJF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.